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Abstract
Objective—To assess clinical success and safety of endoscopic pharyngoesophageal dilation
after chemoradiation or radiation for head and neck cancer and to identify variables associated
with dilation failure.
Study Design—Case series with chart review
Methods—Between 2000 and 2008 one hundred and eleven patients treated with chemoradiation
or radiation for head and neck cancer with subsequent pharyngoesophageal stenosis requiring
endoscopic dilation were identified. Patients were evaluated for endoscopic dilation technique,
severity of stenosis, technical and clinical success and intra and post operative complications. The
Diet/GT Score, range 1–5, was utilized to measure swallow success. Variables associated with
dilation failure were analyzed by univariate and multivariate logistic regression.
Results—271 dilations were analyzed, with 42 combined antegrade retrograde dilations, 208
dilations over a guidewire and 21 dilations without guidewire. Intraoperative patency and
successful dilation of the stenotic segment was achieved in 95% of patients. A Diet/GT score of 5
(gastrostomy tube removed and soft/regular diet) was attained in 84/111 (76%) patients. Safety
analysis showed complications occurred in 9% of all dilations. Perforations were noted in 4% of
all procedures with only two esophageal perforations requiring significant intervention. Multiple
dilations were associated with an increased risk for perforations. Further logistic regression
Corresponding Author and Reprint Requests: Laura A. Goguen, MD, Division of Otolaryngology, Department of Surgery, 75 Francis
Street, Brigham and Women’s Hospital, Boston, MA, USA, 02115, Tel: (617) 525-6500;, Fax: (617) 525-6511 lgoguen@partners.org.
CONFLICT OF INTEREST: None
Oral presentation, Triological Society Combined Sections Meeting, January 24–26, 2013 in Scottsdale, Arizona, U.S.A.
FINANCIAL DISCLOSURE:
i. Salary for Anna Snavely, PhD was supported by NIH grant (2 T32 CA 9337-31)
ii. none of the authors has any financial interests
iii. no other financial disclosures
NIH Public Access
Author Manuscript
Laryngoscope. Author manuscript; available in PMC 2014 January 31.
Published in final edited form as:













analyses revealed that the number of dilations was indicating a poor outcome and low Diet/GT
score.
Conclusion—Pharyngoesophageal stenosis, occurring after chemoradiation and radiation
treatment, can be successfully and safely treated with endoscopic dilation techniques. Patients
with restenosis, requiring multiple dilations, have a higher risk of persistent dysphagia.
Level of Evidence—2b individual retrospective cohort study
Keywords
esophageal stenosis; pharyngoesophageal stenosis; dysphagia; esophageal dilation; head and neck
cancer; CARD
Introduction
Head and neck cancer (HNC) is the fifth most common cancer worldwide and accounts for
approximately 3% of all malignancies in the US.1,2 More than 90 % of HNC are squamous
cell cancers.3 Survival for patients with advanced stage disease undergoing adjuvant or
primary Chemoradiation (CRT) regimens has increased4–8 but is sometimes associated with
late toxicities that may diminish the patient’s quality of life.9 Dysphagia, caused by partial
or complete esophageal stenosis, is a particularly debilitating treatment consequence. The
close proximity of mucous membranes in the pharyngoesophageal area make this site
especially susceptible for stenosis formation.10 The healing process after radiation damage,
involving fibrosis and scar tissue formation, can result in a concentric stricture.11 A recently
published meta-analysis describes the risk for pharyngoesophageal stenosis in HNC with
conventional radiation treatment (RT) to be 5.7% and notes a more than three fold increase,
to 16.7%, with intensity modulated RT in combination with chemotherapy.12,13
Most patients have partial stenoses that are amenable to standard antegrade esophageal
dilation techniques with low rates of esophageal perforation. Dilation of complete
esophageal stenosis is more technically challenging but can be successfully achieved
through a combined antegrade and retrograde endoscopic dilation (CARD) technique.14
The aim of this retrospective study is to assess success rates and safety of endoscopic
esophageal dilation in HNC patients who have undergone CRT or RT. Additionally we aim
to identify variables associated with poor outcome after esophageal dilation.
Methods
A retrospective analysis was performed on HNC patients that underwent antegrade or
CARD pharyngoesophageal dilation between January 2000 and December 2008. Patients
were identified by searching the database for all patients that underwent esophageal dilation
after CRT or RT for HNC at the Dana-Farber Cancer Institute and Brigham and Women’s
Hospital. Treatment regimens included primary concurrent or sequential CRT/RT, and
primary surgery with adjuvant CRT/RT. The study population consisted of patients with
primary tumors in the oral cavity, orophaynx, hypopharynx, larynx, nasopharynx and
unknown primaries. All patients had a minimum follow up of 12 months after the initial
dilation. Patients with thyroid tumors or primaries outside the head and neck area, such as
lung cancers or esophageal cancers, or with recurrence in the stenotic segment were
excluded. The protocol was approved by the institutional review board.
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Prior to endoscopic esophageal dilation, dysphagia assessment with a video swallowing
study was undertaken in most patients. Stricture location was categorized as:
cricopharyngeal, esophageal, or pharyngeal. Stricture severity was endoscopically gauged
by the size of the stenotic segment: complete stenosis; partial stenosis ≤ 5mm; and partial
stenosis > 5mm.
Dysphagia assessment pre and post dilation
Dysphagia assessment included diet consistency and gastrostomy tube (GT) status pre
dilation and one, three, six and 12 months post dilation. Prior to RT or CRT all patients were
recommended to undergo GT placement. Diet was described in five categories: NPO, liquid,
pureed, soft or regular diet. As a measurement for success of dilation, the Diet/GT Scale was
utilized.15 The five level scoring system, combines GT status and diet: Score 1, GT present
and NPO; Score 2, GT present and liquid pureed/diet; Score 3, GT present and soft/regular
diet; Score 4, no GT and liquid/pureed diet; Score 5, no GT and soft/regular diet.
Endoscopic dilation procedures
Patients with complete pharyngoesophageal stenosis underwent CARD via a technique
previously described by Goguen et al.14 Patients with partial stenosis, whereby a guidewire
could be passed through the stenotic segment, underwent antegrade dilation using a
guidewire and progressively larger dilators (Savory-Gilliard guidewire, Cook Endoscopy,
Winton-Salem, NC). Alternatively, a smaller subset of patients with partial stenosis
underwent antegrade dilation without a guidewire. Dilation technique was at the discretion
of the surgeon. Repeat dilations were performed based on the patient’s dysphagia symptoms.
Shortly after dilation patients followed up with their swallow therapist to establish a safe
oral diet and to continue swallow therapy.
Statistics
Univariate and multivariate logistic regression analyses were performed to evaluate possible
variables associated with dilation failure and with perforation. Factors included in the
analyses were clinical and treatment factors, including age, gender, size of stenosis, T-and
N-stage, type of treatment, pre dilation diet, complications, time of dilation and number of
dilations. Post dilation Diet/GT Score of 1, 2 or 3 was considered a poor outcome and
defined as dilation failure. The Wald Chi-square test from the logistic regression model was
used to test for statistical significance. Variables with p values <0.25 were considered for
model building of the multivariate analyses. A 2-sided p value of <0.05 was considered as
statistically significant. Time from dilation to GT removal was analyzed using the method of
Kaplan and Meier. SAS, version 9.2 (SAS Institute, Cary, NC) was used for all analyses.
Results
Patient characteristics
One hundred and eleven patients met inclusion criteria for this study (Table 1).
Evaluation of swallowing function
The median time from completion of CRT/RT to first dilation was 5.9 months (range 2.3–
99.6 months). The majority of patients, 95/111 (86%), had a videofluoroscopy done prior to
first dilation, which demonstrated partial or complete stenosis in 91% (86/95) patients.
Videofluoroscopy showed further swallowing impairment, mostly oropharyngeal dysphagia,
in 72% of those patients. At the time of dilation, 92/111 (83%) patients were GT dependent,
and 19/111 (17%) patients had their GTs removed. Patients swallowing function was further
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evaluated according to dietary intake pre dilation (Table 2). Thirty three percent, (37/111)
patients, were unable to take any oral diet, 21% (25/111) took an oral diet with soft or
regular food.
Pharyngoesophageal stenosis
Stenoses were found in most patients at the cricopharyngeal or upper cervical esophageal
regions, 109/111 (98%). Only 2 patients had stenosis in other areas of pharynx including
base of tongue and hypopharynx. Three patients had longer stenosis extending over multi
regions from hypopharynx to cervical esophagus. Partial stenosis with lumen >5mm was
found in 61% patients, ≤5mm stenosis in 18% and complete stenosis in 21% of patients at
time of first dilation. A total of 271 dilations were performed. Repeat dilations were needed
in 65/111 (59%) patients (Table 3). On average, each patient underwent 2.4 dilations, and
the median number of dilations per patient was 2.
Dilation techniques
Three different dilation techniques were recorded during the observation period (Table 3).
Dilation over a guidewire was the most common technique in patients with partial stenosis.
Some patients (11 patients), with minor partial stenosis, underwent dilations without a
guidewire (21 dilations). The size of partial stenosis ranged from 3–14mm before the first
dilation, and antegrade dilation achieved a lumen between 12–20mm in these patients.
Twenty-two patients with complete esophageal stenosis underwent CARD. Successful
CARD dilations, in patients with complete stenosis, achieved a lumen between 10–20mm.
Success of endoscopic esophageal dilation
Success of the endoscopic dilation was assessed by the following measures: the ability to
achieve intraoperative pharyngoesophageal patency and dilation of the stenotic segment,
oral diet, GT dependence and Diet/GT Score at 1, 3, 6 and 12 months post dilation (Table 2).
In 106/111 (95%) patients, the initial dilation accomplished intraoperative patency and the
stenotic segment was dilated. Median Diet/GT Score pre dilation was 2 (GT dependent with
liquid/pureed diet) and patients showed improved median Diet/GT Score of 3 (GT
dependent with soft/regular diet) at one month and of 5 (GT independent with soft/regular
diet) at 12 months after dilation (Figure 1). One month after dilation biggest improvement in
swallowing function was observed in patients with initial Diet/GT Score of 1 and 2 whose
Diet/GT Scores increased in 70% (26/37) and 65% (28/43) respectively (Figure 2). One year
after dilation 104/111 (94%) achieved an oral diet and the GT was removed in 87/111 (78%)
patients (Figure 3).
Additional swallow recovery was noted after the one year post dilation observation period.
Further assessment at 24 months revealed that 98/111 patients (88%) had their GTs
removed.
Patients with persistently poor swallowing function
Seven of 111 (6%) patients remained GT dependent and NPO at one year post dilation. This
group had diverse patient characteristics (Table 4): 4/7 patients had complete stenosis
requiring CARD and in 1/4 intraoperative pharyngoesophageal patency was not attained. Six
of seven patients had between 2 and 8 repeat dilations. Two patients were able to become
GT independent at a later time point between 18 and 24 months.
Complications after endoscopic esophageal dilation
There were no deaths associated with the dilation procedures. The complication rate per
dilation procedure was 9% (25/271) and included: 8/208 (4%) in antegrade guidewire
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dilations; 1/21 (5%) in dilations without guidewire and 16/42 (38%) CARD (Table 5).
Complications requiring significant intervention were 4/271 (1.4%).
Perforation was the most common complication encountered in 11/271(4%) dilations,
whereby 7/42 (16%) perforations occurred in CARD and 4/208 (2%) perforations in
antegrade guidewire dilations. These perforations were mostly microperforations, 7/271
(2.5%), and resulted in pneumothorax, pneumomediastinum or subcutaneous emphysema in
the neck appreciated on post procedure chest radiograph. Patients were treated with
intravenous antibiotics, observed in the hospital, and followed with serial chest radiographs.
No further intervention was required for those patients with microperforations.
A perforation requiring more intervention occurred in four patients. Two patients, who
underwent guidewire dilation developed pharyngocutaneous fistulas that resolved with
intravenous antibiotics and wound packing. Chest tube placement and temporary pharyngeal
stent for treatment of pneumothorax and pharyngeal tear, was necessary in one CARD
patient. Additionally, one patient developed an epidural abscess after antegrade guidewire
dilation that required spinal canal decompression This patient recovered completely
following a prolonged 34-day hospital stay, and was able to tolerate a soft diet but remained
GT dependent throughout the follow up period.
Univariate logistic regression analyses for risk factors of perforations were performed.
Variables included were T-stage, N-stage, Overall stage, treatment and number of dilations.
A higher number of dilations was associated with an increased risk of perforation (p=0.004,
OR=1.7, 95% CI 1.2–2.3).
Among patients receiving CARD, GT site complications were found in 8/42 (19%)
dilations. These included pneumoperitoneum and leakage around the GT site. Almost all of
those patients were treated conservatively with observation and serial chest or abdominal
radiographs with successful resolution of pneumoperitoneum. Exchange of GT in the
operating room was only necessary for one patient.
Although the vast majority of complications did not require a return to the operating room,
an increased length of hospital stay, was seen in 18/25 (72%) of the procedures with
complications. Assessment of diet and GT status after a complicated dilation procedure
showed that 17/22 patients had their GT removed and were able to eat a soft or regular diet.
Analysis of Factors Affecting Successful Dilation
Univariate logistic regression analyses were performed to look for associations with poor
outcome after dilation (Table 6). A low Diet/GT Score, group 1–3, at one year after initial
dilation was used to define patients with a poor dilation outcome. Results indicated that an
increasing number of dilations during the first year was strongly associated with a poor
outcome. Patients with higher T-stage had a tendency to perform worse, as well as patients
where the initial dilation procedure was performed 6 months after the end of CRT, but both
factors did not reach statistical significance. The extent of stenosis, considering complete
stenosis involving CARD dilation, versus partial stenosis, was not associated with worse
outcome.
In the multivariate model, after controlling for sex, T-stage, time of dilation, pre dilation diet
and complete versus partial stenosis, number of dilations remained statistically significant
(p=0.04, OR=1.5, 95% CI 1.02–2.09).
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Pharyngoesophageal strictures are a frequent problem encountered in patients with HNC
treated with combined modality therapy. Partial stenosis develops in 9–21%11,16,17 and
complete stenosis in 0.8–4%.10,13 Endoscopic therapy, with antegrade or ante-retrograde
esophageal dilations, is an established treatment to alleviate pharyngeal or esophageal
stenosis post HNC treatment. However, only few studies have looked at management and
outcome of endoscopic dilations in this patient group.14,18,19 The purpose of this study was
to assess success and safety of dilation procedures in HNC patients post treatment. We
identified 111 patients who underwent 271 endoscopic esophageal dilations following HNC
treatment making this one of the largest and most detailed studies in the literature.
Our results show that technical success, as seen by achieving intra-operative esophageal
patency and dilating the stenosis was successful in 95%. Similar results were found by Dhir
et al,19 who attained esophageal patency in 20/21 patients dilated with antegrade guidewire
technique. Another case series by Ahlawat et al.20 reported technical success in 80% of
patients, also treated with antegrade guidewire dilations.
The measures for functional success of dilations in our study were GT status, diet and the
Diet/GT Score. Other dysphagia scales used in HNC patients are the Swallowing
Performance Status Scale (SPSS)21 or the functional oral intake scale (FOIS).22 The SPSS
requires a videofluoroscopy for assessment that was not available for all of our patients post
dilation. The FOIS was validated in stroke patients and only recently applied to HNC
patients by Kotz et al.23 in a prospective randomized trial. In the retrospective setting of this
study we chose the Diet/GT Score because it combines the two objective criteria diet and
GT status and was previously applied to HNC patients successfully from our group. 15
Small patient numbers in other case series and diverse approaches for reporting dilation
success make a comprehensive comparison of our results challenging. An improvement
from median pre-dilation Diet GT Score of 2 to median score of 3 was observed 1 month
after dilation. Successful removal of GT was found in 78% after one year and 88% after two
years. Dhir et al.19 used a dysphagia scale and reported adequate dysphagia relief in 75%
patients. These patients had either no dysphagia or occasional dysphagia to solids 4–36
weeks post procedure. The same dysphagia scale was used by Ahlawat et al.,20 reporting
84% adequate dysphagia relief. GT status was not reported in these studies. Other smaller
case series on CARD dilations stated improvement in oral intake in 6/7 patients.24
The majority of our patients achieved intra-operative esophageal patency, yet a significant
number, 49% (54/111), required repeat dilations. This is consistent with other clinical
studies demonstrating the need for multiple dilations.18,20,24,25 Case series reports, using
antegrade dilation technique, identified the need for multiple dilations in 74%,26 58%20 and
33%.19 For patients undergoing an initial CARD dilation, Fowlkes et al.18 reported an
average need of 7 anterograde dilations following the initial CARD procedure. Comparing
this data to our case series, repeated antegrade dilations were required in most CARD
patients with an average of 3 dilations following CARD.
Beyond the technical success, many other factors influence swallowing post dilation. As
seen on pre dilation video swallow, 72% of our patients additionally had oropharyngeal
phase swallow dysfunction. This is the result of tissue edema, deformed anatomy and
immobility of the larynx and cricoid due to post radiation changes.20,27,28 All of our study
patients participated in post CRT swallow therapy as a crucial part of their treatment.
Specific swallowing exercises directed towards structures impaired during and after CRT
have been shown to improve swallowing outcome. 23,29–31 Therefore we believe not all
swallowing improvement noted in the observation period, especially at long term follow up,
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can be attributed to the dilation procedures. Rather multiple factors contribute to swallowing
recovery, including: dilation procedures, swallow therapy, and post radiation tissue recovery
over time.
Our overall complication rate was low at 9% for a total of 271 dilations demonstrating that
phayrngoesophageal dilations are relatively safe. The most common complications were
perforations (4%) which occured usually as microperforations and resolved spontaneously.
A case series by Hernandez et al.32 reported a similar rate of 3.9% for anterograde dilations.
Higher perforation rates between 17%–25% were noticed for CARD dilations. 27,33 Unique
to CARD were GT site complications observed in 19% of our CARD procedures which
were managed successfully with observation in the majority of cases. In other smaller case
series, GT complications were seen in 12%.18,33 Dilation of the GT site to permit retrograde
passage of flexible gastroscope is the main factor contributing to these complications. In
general our large patient series revealed mainly minor complications but there remains a risk
for serious complications, particularly related to pharyngoesophageal perforations, and
diligent postoperative care is needed.
Conclusion
In conclusion, our study shows that anterograde and combined ante-retrograde dilation
techniques are not only a safe but also a very successful treatment method for HNC patients
with pharyngoesophageal strictures after CRT and RT treatment. The number of dilations
within the first year was associated with persistent dysphagia and a risk for perforation.
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Figure 1. Diet/GT Score pre and post dilation
Diet/GT Score pre dilation and 1 month and 12 months post dilation.
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Figure 2. Change in Diet/GT Score
Visualization of change in Diet/GT Score at 1 month post dilation (A) and 12 months post
dilation (B) compared to pre dilation score.
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Figure 3. GT dependence after dilation
GT removal rate within 24 months following dilation.
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 Male 78 70.3%
 Female 33 29.7%
Age
 Median, range 57.7, 39–84
Primary Tumor Site
 Oropharynx 55 49.6%
 Hypopharynx 8 7.2%
 Larynx 15 13.5%
 Oral Cavity 8 7.2%
 Nasopharynx 10 9.0%
 Unknown Primary 15 13.5%
T-stage
 T0 15 13.5%
 T1 30 27.0%
 T2 31 27.9%
 T3 25 22.5%
 T4 10 9.0%
N-stage
 N0 20 18.0%
 N1 18 16.2%
 N2 58 48.6%
 N3 15 13.5%
Overall Stage
 1 2 1.8%
 2 9 8.1%
 3 25 22.5%
 4 75 67.6%
Treatment
 Primary CRT/RT 99 89.2%
 Primary Surgery; post CRT/RT 12 10.8%
Post CRT ND
 No 76 68.5%
 Yes 35 31.5%
Size of Stenosis
 ≤ 5mm 21 18.9%
 > 5mm 68 61.3%
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Factors N %
 Complete 22 19.8%

















































































































































































































































































































































































































































































































































Total No. of dilations 271
Dilation technique
Guidewire dilation 208
Dilation without guidewire 21
Ante-retrograde dilation 42
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Table 5
Complications
Complication No dilations (%) Type of dilation Management
All Complications in 22 patients 25/271 (9%) CARD 16
GW 8
B 1
Increased length of hospital 18/271 (6%) CARD 13
GW 5
All Perforations 11/271 (4%) CARD 7
GW 4
Microperforations with no interventions 7/271 (2.5%) CARD 6
GW 1
7 patients i.v. Antibiotics, observation, serial CXR,
1 patient GT placement
Perforation requiring minor intervention
(Pneumothorax and Pharyngocutaenous
fistula)
3/271 (1%) CARD 1
GW 2
1 patient chest tube placement and Poly flex stent,
2 patients i.v. Antibiotics and wound packing
Perforation leading to significant adverse
event Epidural abscess
1/271 (0.4%) GW 1 1 patient with spinal canal decompression
All GT site complications 8/271 (3%) CARD 8
Pneumoperitoneum 5/271 (1.8%) 5 patients with observation
GT lost/replaced 1/271 (0.4%) 1 patient GT replaced at bedside
Extravasation at GT site 1/271 (0.4%) 1 patient GT replaced in OR
Abdominal wall cellulitis 1/271 (0.4%) 1 patient i.v. Antibiotics and observation
Minor infections thrush, mucositis, cellulitis 5/271 (1.8%) CARD 1
GW 3
B 1
2 patients Antimykotikum, 1 patient i.v.
Antibiotics, 1 patient Salivary bypass tube
removed and iv Antibiotics
Other medical, respiratory failure,
intraoperative hypotension, diarrhea
3/271 (1%) CARD 2
GW 1
1 patient requiring intubation, 1 patient with
observation, 1 patient p.o. Antibiotics,
GT- gastrostomy tube, CARD- combined ante-retrograde dilation, GW- guidewire, B-bougie dilator
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Table 6
Univariate Logistic Regression Results
Factor OR 95% CI p-value
Gender (Female vs. Male) 2.3 (0.9, 5.8) 0.08
Complete Stenosis (yes vs. no) 2.4 (0.9, 6.7) 0.09
T-stage (ordinal) 1.4 (0.97, 2.12) 0.07
N-stage (ordinal: N0, N1, N2, N3) 0.8 (0.5, 1.3) 0.42
Overall Stage (ordinal) 0.9 (0.5, 1.7) 0.76
Post CRT Neck Dissection (yes vs. no) 1.0 (0.4, 2.7) 0.95
Treatment (Primary surgery vs. CRT/RT) 0.6 (0.1, 3.2) 0.61
Pre-Dilation Diet (NPO vs. other) 2.1 (0.8, 5.3) 0.12
Time (> 6 months vs. ≤ 6 months) 2.4 (0.9, 5.9) 0.07
Complications (yes vs. no) 1.9 (0.6, 6.2) 0.29
# Dilations in 1st Year (continuous) 1.6 (1.1, 2.1) 0.005
Age at Diagnosis (continuous) 1.02 (0.97, 1.06) 0.50
The outcome for these models is having a GT/Diet Score of 1, 2, or 3.
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